PLASMA FROM PATIENTS WITH IDIOPATHIC AND HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA INDUCES APOPTOSIS IN MICROVASCULAR ENDOTHELIAL-CELLS
J. Laurence et al., PLASMA FROM PATIENTS WITH IDIOPATHIC AND HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA INDUCES APOPTOSIS IN MICROVASCULAR ENDOTHELIAL-CELLS, Blood, 87(8), 1996, pp. 3245-3254
The pathogenesis of thrombotic thrombocytopenic purpura (TTP) is obscu
re. It is manifested classically by platelet thrombi and localized mic
rovascular endothelial cell (EC) proliferation, in the absence of an i
nflammatory response. It is statistically associated with human retrov
iral disease, but pathological studies of TTP lesions have been unable
to establish whether perturbation of the endothelium is a primary or
secondary event, irrespective of the presence of retroviral infection.
We document that plasma from all of four acute TTP patients, with or
without human immunodeficiency virus infection, can induce apoptosis i
n cultured ECs of microvascular but not large vessel origin. This proc
ess was documented by three different methods, (1) laser-illuminated l
ight scatter, (2) quantitation of the pre-G(1) A(o) peak on DNA histog
rams and direct visualization of chromatin fragmentation by acridine o
range and 4'6-diamidino-2-phenylindole staining, and (3) agarose gel e
lectrophoresis of low molecular weight cellular DNA. Apoptosis was ind
ependent of tumor necrosis factor-alpha secretion or the presence of C
D36 on microvascular ECs but was linked to the rapid induction of Fas
(CD95) on these cells, Soluble anti-fas antibody, normal plasma deplet
ed of cryoprecipitate, and low concentrations (less than or equal to 0
.1 mu mol/L) of aurintricarboxylic acid were capable of suppressing TT
P plasma-mediated EC apoptosis. In conclusion, microvascular EC apopto
sis may be of pathophysiological importance in TTP may be susceptible
to interruption by blockade of initiating signals for, or final common
enzyme pathways leading to, programmed cell death. (C) 1996 by The Am
erican Society of Hematology.